Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitorsZhongmin Yang, Ze‐Hong Miao|Acta Pharmacologica Sinica|2017Cited by 31